233 related articles for article (PubMed ID: 9416006)
1. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
3. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
Brown L; Erdmann E; Thomas R
Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
[TBL] [Abstract][Full Text] [Related]
4. Binding of dihydrodigitoxin to beef and human cardiac (Na+ + K+)-ATPase: evidence for two binding sites in cell membranes.
Brown L; Erdmann E
Biochem Pharmacol; 1983 Nov; 32(21):3183-90. PubMed ID: 6315020
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
6. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion.
Schmidt TA; Svendsen JH; Haunsø S; Kjeldsen K
Basic Res Cardiol; 1990; 85(4):411-27. PubMed ID: 2173546
[TBL] [Abstract][Full Text] [Related]
8. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
9. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
Palasis M; Kuntzweiler TA; Argüello JM; Lingrel JB
J Biol Chem; 1996 Jun; 271(24):14176-82. PubMed ID: 8662895
[TBL] [Abstract][Full Text] [Related]
10. Effects of sodium iodide, lithium bromide, and deoxycholate on dissociation of [3H]ouabain-Na,K-ATPase complex during enzyme isolation.
Nandi DL; Okita GT
Mol Pharmacol; 1980 Sep; 18(2):259-66. PubMed ID: 6252440
[No Abstract] [Full Text] [Related]
11. Stability of [3H]ouabain binding to the (Na+ + K+)-ATPase solubilized with C12E8.
Inaba M; Maede Y
Biochim Biophys Acta; 1985 Aug; 818(2):267-70. PubMed ID: 2992592
[TBL] [Abstract][Full Text] [Related]
12. Glutamic acid 327 in the sheep alpha 1 isoform of Na+,K(+)-ATPase is a pivotal residue for cation-induced conformational changes.
Johnson CL; Kuntzweiler TA; Lingrel JB; Johnson CG; Wallick ET
Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):187-94. PubMed ID: 7619055
[TBL] [Abstract][Full Text] [Related]
13. Two different modes of inhibition of the rat brain Na+, K(+)-ATPase by triterpene glycosides, psolusosides A and B from the holothurian Psolus fabricii.
Gorshkova IA; Kalinin VI; Gorshkov BA; Stonik VA
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Jan; 122(1):101-8. PubMed ID: 10190033
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
15. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
Brinkmann K; Linnertz H; Amler E; Lanz E; Herman P; Schoner W
Eur J Biochem; 1997 Oct; 249(1):301-8. PubMed ID: 9363783
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a partially purified Na+,K+-ATPase from dog heart.
Sulakhe PV; Elimban V; Dhalla NS
Adv Myocardiol; 1985; 6():249-57. PubMed ID: 2986258
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Na+,K(+)-ATPase in tachycardia induced cardiomyopathy.
Spinale FG; Clayton C; Tanaka R; Fulbright BM; Mukherjee R; Schulte BA; Crawford FA; Zile MR
J Mol Cell Cardiol; 1992 Mar; 24(3):277-94. PubMed ID: 1320703
[TBL] [Abstract][Full Text] [Related]
19. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
Ozaki H; Nagase H; Urakawa N
Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of ouabain binding to native and mutated forms of Na,K-ATPase and identification of a new region involved in cardiac glycoside interactions.
Schultheis PJ; Wallick ET; Lingrel JB
J Biol Chem; 1993 Oct; 268(30):22686-94. PubMed ID: 8226778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
